Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nanotis, a Japan-based infectious disease diagnostics developer spun out of University of Tokyo, has raised a pre-series A round of undisclosed size from pharmaceutical company Taisho Pharmaceutical for research and development for rapid diagnostic devices. The company had secured ¥45m ($402,000) in October 2018 from financial services firm Shizuoka Bank’s Shizuoka Capital unit, light technology…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.